Palatin Technologies Inc PTN

US Biotechnology

$9.12 ▼ -4.80% ($-0.46)

🔥 High Short Interest 🎈 Low Float 📅 Earnings This Week

Open $9.54

Prev Close $9.58

Day Range $9.04 – $9.69

52W Range $5.61 – $31.00

Market Cap $16.23M

Beta 0.72

EPS (TTM) $-1.69

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NYSE MKT LLC
Currency	USD
IPO Date	1999-12-21
Shares Out.	1,780,000
Website	palatin.com/ ↗
Phone	16094952200
Employees	29
Revenue	$300,770
Gross Profit	$300,770
Net Income	-$4.4M
Free Cash Flow	-$13.6M
Total Assets	$8.5M
Total Liabilities	$1.8M
Equity	$6.7M

About Palatin Technologies Inc

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

Palatin Technologies Inc is a publicly traded company under the ticker symbol PTN on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.